Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Although rheumatologists consider chimeric antigen receptor T-cell therapy “potentially transformative,” nearly 70% remain ...

A new study led by researchers at the UNC School of Medicine and Cartesian Therapeutics, found that immunotherapy can help ...

At Liv Hospital, specialists emphasize that stem cell therapy isn’t a one-size-fits-all solution. Instead, it is carefully indicated for specific diseases, patient profiles, and treatment ...

The Supreme Courts latest ban on the use of stem cell therapy for autism serves as a vital reminder that miracle cures often ...

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients with severe, treatment-refractory systemic lupus erythematosus.

The Supreme Court has ruled that stem cell therapy cannot be offered as a treatment for Autism Spectrum Disorder, calling its use outside approved clinical trials unethical and medical malpractice.

Catalent made a series of deals early this decade to build up its presence in Gosselies. Now, it's planning to wind down cell ...

Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

AstraZeneca has outlined plans to invest $15 billion in China through 2030, making a broad commitment to the country to ...